Investors Hangout Stock Message Boards Logo
  • Home
  • Mailbox
  • Boards
  • Favorites
  • Whats Hot!
  • Login - Join Now!
Profile
reallypeople?'s Profile
Displaying 1201-1250 of 1754 result(s).
CYDY CytoDyn Inc
06/07/2020 6:43:37 PM
Who might die https://www.google.co (1)
CYDY CytoDyn Inc
06/07/2020 5:57:01 PM
Newest figures very low . Not all d
CYDY CytoDyn Inc
06/07/2020 5:54:17 PM
I think the highest I’d seen is 6
CYDY CytoDyn Inc
06/07/2020 5:48:02 PM
If you can’t decide then thats a
CYDY CytoDyn Inc
06/07/2020 5:44:22 PM
Anyone look at article I posted and
CYDY CytoDyn Inc
06/07/2020 3:28:20 PM
Top contender Leronlimab https://ww (1)
CYDY CytoDyn Inc
06/07/2020 9:47:50 AM
Another no https://www.statnews.com
CYDY CytoDyn Inc
06/06/2020 10:02:47 PM
Good night
CYDY CytoDyn Inc
06/06/2020 9:32:11 PM
Dude sounds like I was exactly corr
CYDY CytoDyn Inc
06/06/2020 5:51:59 PM
I don’t think so relisten and let (1)
CYDY CytoDyn Inc
06/06/2020 5:48:33 PM
Green flaming . Sweden was never lo
CYDY CytoDyn Inc
06/06/2020 5:38:37 PM
You said Remember, he stopped BP fr
CYDY CytoDyn Inc
06/06/2020 5:35:15 PM
I’ve seen a couple figures one at
CYDY CytoDyn Inc
06/06/2020 10:46:50 AM
That’s what I said 3rd in-line un
CYDY CytoDyn Inc
06/06/2020 10:26:28 AM
Sorry for confusion.. most per your
CYDY CytoDyn Inc
06/06/2020 10:02:07 AM
What percentage is most ??
CYDY CytoDyn Inc
06/06/2020 9:48:25 AM
Labs are considered as other ,,, 3
CYDY CytoDyn Inc
06/05/2020 10:19:53 PM
Everyone listen to NP . On this new (3)
CYDY CytoDyn Inc
06/05/2020 8:49:48 PM
Crush the street interview . NP get
CYDY CytoDyn Inc
06/05/2020 8:44:33 PM
Thanks for reading . Are we really
CYDY CytoDyn Inc
06/05/2020 7:45:53 PM
Maybe we get a mention in a NIH pre
CYDY CytoDyn Inc
06/05/2020 7:41:54 PM
NIH article cd8 cells mentioned int
CYDY CytoDyn Inc
06/05/2020 7:39:25 PM
Can you send that privately please
CYDY CytoDyn Inc
06/05/2020 5:42:58 PM
Why didn’t link the second one ??
CYDY CytoDyn Inc
06/05/2020 5:21:05 PM
Left on
CYDY CytoDyn Inc
06/05/2020 2:01:04 PM
I had a support level at 2.72-2.74
CYDY CytoDyn Inc
06/05/2020 1:57:30 PM
I absolutely noticed his face early (1)
CYDY CytoDyn Inc
06/05/2020 1:47:26 PM
NP just needs speak in absolute ter
CYDY CytoDyn Inc
06/05/2020 10:44:53 AM
Absolutely true , seen my father ge (1)
CYDY CytoDyn Inc
06/04/2020 10:51:21 PM
How many shares left on the availab
CYDY CytoDyn Inc
06/04/2020 9:52:38 AM
True but only selling of those shar (1)
CYDY CytoDyn Inc
06/04/2020 9:44:51 AM
What percentage just get better in (1)
CYDY CytoDyn Inc
06/04/2020 9:40:11 AM
It sounds crazy for some of you but (2)
CYDY CytoDyn Inc
06/04/2020 9:25:23 AM
See if NK stock symbol ..has a tria (1)
CYDY CytoDyn Inc
06/03/2020 11:38:11 PM
My pick for a buyout would be Abbvi
CYDY CytoDyn Inc
06/03/2020 5:59:42 PM
Have you researched the cost ? . Cy (1)
CYDY CytoDyn Inc
06/03/2020 4:39:28 PM
Correct . Glad someone like yoursel
CYDY CytoDyn Inc
06/03/2020 4:28:32 PM
Who are you god or the board police
CYDY CytoDyn Inc
06/03/2020 4:13:10 PM
I believe any patient can come off
CYDY CytoDyn Inc
06/03/2020 1:24:47 PM
Love NP but his comments are questi (2)
CYDY CytoDyn Inc
06/03/2020 1:23:01 PM
Not at all just believe the FDA doe (1)
CYDY CytoDyn Inc
06/03/2020 1:04:17 PM
I DONT THINK SO.. It is an assumpti (1)
CYDY CytoDyn Inc
06/03/2020 10:49:44 AM
FDA has plenty of time before Mexic
CYDY CytoDyn Inc
06/03/2020 10:22:22 AM
So this company is a small manufact
CYDY CytoDyn Inc
06/03/2020 10:17:20 AM
Good thoughts but Mexico trial wasn
CYDY CytoDyn Inc
06/03/2020 9:16:09 AM
Stop EIND . What’s fda really say (1)
CYDY CytoDyn Inc
06/03/2020 9:05:32 AM
Can you refresh me on Remdesivir tr
CYDY CytoDyn Inc
06/02/2020 10:03:29 PM
blafarm that’s a great thought an
CYDY CytoDyn Inc
06/02/2020 3:48:01 PM
If anyone has contact with Dr B ,,D
CYDY CytoDyn Inc
06/02/2020 3:20:45 PM
Severe Critical Primary Outcome Mea
Go to page:
  • << First
  • < Previous
  • 24
  • 25
  • Next >

Recent Articles

  • Shareholder Advocacy: An Insight into Recent Investigations
  • Lecanemab's Promising Impact Presented at Alzheimer Conference
  • Exploring Lecanemab's Efficacy and Safety at the AAIC Conference
  • Evyve Partners with Tritium on Groundbreaking Charging Solution
  • AI Smart Glasses Market Projects 11.09% Growth Through 2032
  • Diversified Energy Company Updates Share Buyback Strategy
  • Scancell's Immunobody® iSCIB1+ Shows Promising Phase 2 Results
  • OSB Group Concludes Own Share Purchase with Key Insights
  • Statkraft’s Second Quarter Performance: Navigating Challenges Ahead
  • Bavarian Nordic's Chikungunya Vaccine Advances with Health Canada
  • ICG Enterprise Trust Achieves Significant Milestone with Datasite
  • Foresight Group Holdings Achieves Successful Share Buyback
  • Updates on ING's Share Buyback Program Progress and Impact
  • Examining NB Private Equity Partners' Recent NAV and Strategy
  • Arco Vara AS Shifts Focus by Exiting Bulgarian Operations
  • Harrison Global Holdings Inc. Soars Following Idealize Deal
  • Statkraft's Strong Q2 Performance Amid Price Challenges
  • Transforming Contact Centers: AI Solutions from TCN
  • Celebrate 30 Years of Toy Story at Tokyo Skytree Event
  • Vallourec's Strategic Site Sale Agreement Enhances Future Growth
  • Sanofi Strengthens Vaccine Portfolio with Vicebio Acquisition
  • Aalberts Shares Buyback Update: Progress and Insights
  • Embla Medical hf Reports Strong Q2 Growth and Future Outlook
  • Alfa Laval AB's Latest Report: Highlights and Insights
  • Embla Medical hf Reports Strong Q2 2025 Financial Performance
  • Alfa Laval AB Releases Q2 2025 Results: Highlights and Insights
  • Transforming Education: Launch of ArthurAI by MindHYVE.ai™
  • Vicebio's Bold Move Towards Integrated Vaccine Development
  • Sanofi's Strategic Acquisition of Vicebio: A New Era for Respiratory Vaccines
  • Vallourec and VINCI Immobilier: A New Era for Déville-Lès-Rouen
  • Aalberts' Share Buyback Program: Latest Updates and Insights
  • Anthropic CEO's Controversial Decision Sparks Debate on Ethics
  • Rise Up Trading Hub Launches Innovative AI Trading Solutions
  • Embla Medical's Profitable Growth Journey Unveiled in Q2 Report
  • Martijn Bergink Takes Helm of Marine Division at Alfa Laval
  • Alina Bonsell: A Game-Changer for NYC Council District 5
  • Transforming Accounting: QuickBooks Sets New Standards in Automation
  • Greener Power Solutions Welcomes New Leadership for Growth
  • Martijn Bergink Takes the Helm at Alfa Laval's Marine Division
  • dsm-firmenich's Share Repurchase Program: Progress Update
  • Wereldhave Delivers Strong Half-Year Results for 2025
  • LHV Group Reports Strong Growth and Financial Performance
  • Hydro's Financial Resilience and Strategic Adjustments
  • Wereldhave Achieves Significant Growth in H1 2025
  • LHV Group's Impressive Financial Performance in Recent Quarter
  • Greener Power Solutions Welcomes Jasper van den Driest as CEO
  • STARFLYER Inc. Enhances Loyalty Services with IBS Software
  • Future Growth of Naphthalene Sulfonate Market Analyzed
  • Explosive Growth: Globavend Holdings Stock Surges 37.99%
  • Syed Javeed Shah Among Top 5 Finalists for Prestigious Award
  • Home - Investors HangoutHome

  • Mailbox - Investors HangoutMailbox

  • Boards - Investors HangoutBoards

  • Favorites - Investors HangoutFavorites

  • Whats Hot! - Investors HangoutWhats Hot!

  • More - Investors HangoutMore

  • Settings - Investors HangoutSettings
  • Login - Investors HangoutLogin
  • Live Site - Investors HangoutLive Site